Empath Medical’s Telemed Approach for Hepatitis C Treatment Shown >90% Effective, Secures $10M
Dr. Andrew Talal, a University at Buffalo Professor of Medicine and leading liver disease expert, first participated in I-Corps in 2020 to evaluate the market fit of a facilitated telemedicine approach for hepatitis C (HCV) treatment in opioid treatment programs.
read more









